Original Research
Published on 16 Jun 2022
Genomic Features of Solid Tumor Patients Harboring ALK/ROS1/NTRK Gene Fusions
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2022.813158
- 5,353 views
- 5 citations
20 articles related to "Solid Tumor Patients"
Articles
Original Research
Published on 22 Feb 2023
Humoral Effect of SARS-CoV-2 mRNA vaccination with booster dose in solid tumor patients with different anticancer treatments
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1089944
- 2,161 views
- 2 citations
Original Research
Published on 05 Jan 2024
Oral microbiome characteristics in patients with pediatric solid tumor
in Microbial Symbioses
Frontiers in Microbiology
doi 10.3389/fmicb.2023.1286522
- 2,560 views
- 6 citations
Original Research
Published on 10 Feb 2025
Assessing hemorrhagic risks in combination therapy: implications of angiogenesis inhibitors and immune checkpoint inhibitors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1527570
- 3,854 views
- 2 citations
Case Report
Published on 08 Jun 2022
Metachronous Multiple Primary Carcinoma With Acute Promyelocytic Leukemia: 2 Cases Report and Literature Review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.893319
- 2,595 views
- 5 citations
Systematic Review
Published on 29 Oct 2020
Systematic Assessment of Risk of Fever in Solid Tumor Patients Treated With PD-1/PD-L1 Inhibitors: A Systematic Review and Meta-Analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2020.570080
- 6,864 views
- 6 citations
Perspective
Published on 14 Feb 2023
TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1097090
- 8,394 views
- 14 citations
Original Research
Published on 07 Jun 2021
Diversity of Dominant Peripheral T Cell Receptor Clone and Soluble Immune Checkpoint Proteins Associated With Clinical Outcomes Following Immune Checkpoint Inhibitor Treatment in Advanced Cancers
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2021.649343
- 6,447 views
- 17 citations
Original Research
Published on 11 May 2017
Anthropometric and Laboratory Variables Related to Weight Loss—Comparison of Heart Failure Patients with Tumor Patients and Control Population
in Clinical Nutrition
Frontiers in Nutrition
doi 10.3389/fnut.2017.00018
- 3,675 views
- 1 citation
Original Research
Published on 24 Jan 2025
Cresp®: transforming the landscape of chemotherapy-induced anemia - a comprehensive retrospective real-world analysis in 523 Indian patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1418327
- 3,590 views
- 1 citation
Original Research
Published on 08 Sep 2025
Bone marrow involvement in solid tumors - a retrospective observational study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1434709
- 1,739 views
- 1 citation
Original Research
Published on 01 Apr 2021
Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.646883
- 5,467 views
- 14 citations
Original Research
Published on 31 Mar 2022
The Efficacy and Safety of Anlotinib in Pediatric Patients With Refractory or Recurrent Solid Tumors
in Obstetric and Pediatric Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.711704
- 3,094 views
- 7 citations
Original Research
Published on 15 Mar 2021
Low-Dose Decitabine Augments the Activation and Anti-Tumor Immune Response of IFN-γ+ CD4+ T Cells Through Enhancing IκBα Degradation and NF-κB Activation
in Cell Growth and Division
Frontiers in Cell and Developmental Biology
doi 10.3389/fcell.2021.647713
- 6,063 views
- 15 citations
Systematic Review
Published on 15 Oct 2021
Intratumor Heterogeneity as a Prognostic Factor in Solid Tumors: A Systematic Review and Meta-Analysis
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.744064
- 4,347 views
- 11 citations
Original Research
Published on 09 Jan 2023
Distinct systemic immune networks define severe vs. mild COVID-19 in hematologic and solid cancer patients
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2022.1052104
- 4,364 views
- 2 citations